Personalized early detection and prevention of breast cancer: ENVISION consensus statement

N Pashayan, AC Antoniou, U Ivanus… - Nature reviews Clinical …, 2020 - nature.com
Abstract The European Collaborative on Personalized Early Detection and Prevention of
Breast Cancer (ENVISION) brings together several international research consortia working …

Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the …

C Canelo-Aybar, M Posso, N Montero, I Solà… - British journal of …, 2022 - nature.com
Background Although mammography screening is recommended in most European
countries, the balance between the benefits and harms of different screening intervals is still …

Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines

HJ Schünemann, D Lerda, C Quinn… - Annals of internal …, 2020 - acpjournals.org
Description: The European Commission Initiative for Breast Cancer Screening and
Diagnosis guidelines (European Breast Guidelines) are coordinated by the European …

Modeled reductions in late-stage cancer with a multi-cancer early detection test

E Hubbell, CA Clarke, AM Aravanis, CD Berg - … Epidemiology, Biomarkers & …, 2021 - AACR
Background: Cancer is the second leading cause of death globally, with many cases
detected at a late stage when prognosis is poor. New technologies enabling multi-cancer …

Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model

N Pashayan, S Morris, FJ Gilbert, PDP Pharoah - JAMA oncology, 2018 - jamanetwork.com
Importance The age-based or “one-size-fits-all” breast screening approach does not take
into account the individual variation in risk. Mammography screening reduces death from …

Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies

JS Mandelblatt, NK Stout, CB Schechter… - Annals of internal …, 2016 - acpjournals.org
Background: Controversy persists about optimal mammography screening strategies.
Objective: To evaluate screening outcomes, taking into account advances in mammography …

Proactive breast cancer risk assessment in primary care: a review based on the principles of screening

JA Usher-Smith, S Hindmarch, DP French… - British Journal of …, 2023 - nature.com
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that
women at moderate or high risk of breast cancer be offered risk-reducing medication and …

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models

C Ming, V Viassolo, N Probst-Hensch… - Breast Cancer …, 2019 - Springer
Background Comprehensive breast cancer risk prediction models enable identifying and
targeting women at high-risk, while reducing interventions in those at low-risk. Breast cancer …

Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes

A Trentham-Dietz, K Kerlikowske, NK Stout… - Annals of internal …, 2016 - acpjournals.org
Background: Biennial screening is generally recommended for average-risk women aged
50 to 74 years, but tailored screening may provide greater benefits. Objective: To estimate …

Cost-effectiveness analyses of genetic and genomic diagnostic tests

K Payne, SP Gavan, SJ Wright… - Nature Reviews Genetics, 2018 - nature.com
Developments in next-generation sequencing technologies have driven the clinical
application of diagnostic tests that interrogate the whole genome, which offer the chance to …